<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2021.784681</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Intermittent Fasting Reshapes the Gut Microbiota and Metabolome and Reduces Weight Gain More Effectively Than Melatonin in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Jingliang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhong</surname> <given-names>Yifan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Luo</surname> <given-names>Xin M.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/216884/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ma</surname> <given-names>Yanfei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Jianxin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/508927/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wang</surname> <given-names>Haifeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/444574/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>College of Animal Science, Zhejiang University, The Key Laboratory of Molecular Animal Nutrition, Ministry of Education</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Biomedical Sciences and Pathobiology, Virginia Tech</institution>, <addr-line>Blacksburg, VA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Lei Zhou, Guangxi University, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Jin Sun, Jiangnan University, China; Xin Wu, Chinese Academy of Sciences (CAS), China; Yimin Jia, Nanjing Agricultural University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Haifeng Wang <email>haifengwang&#x00040;zju.edu.cn</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Nutrition and Metabolism, a section of the journal Frontiers in Nutrition</p></fn></author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>784681</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Liu, Zhong, Luo, Ma, Liu and Wang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Liu, Zhong, Luo, Ma, Liu and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><bold>Background:</bold> Intermittent fasting (IF) can reduce energy intake and body weight (BW). Melatonin has many known functions, which include reducing appetite and preventing excessive weight gain.</p>
<p><bold>Objective:</bold> This study aimed to investigate the effects of IF on body fat and the gut microbiota and metabolome as well as a potential interaction with melatonin.</p>
<p><bold>Methods:</bold> Male C57BL/6J mice (23.0 &#x000B1; 0.9 g, 6 wk old) were randomly assigned into four groups (12 mice/group): control (C), intermittent fasting (F), melatonin (M), and intermittent fasting plus melatonin (MF). The C and M groups mice were provided with <italic>ad libitum</italic> access to food and water, while the F and MF groups underwent alternative-day feed deprivation (15 cycles total). Melatonin was administered in the drinking water of the M and MF groups. Blood, epididymal fat, liver tissue, and intestinal tissue and contents were collected for lab measurements, histology, and microbiota and metabolome analysis. Main effects and interactions were tested by 2-factor ANOVA.</p>
<p><bold>Results:</bold> IF significantly reduced BW gain and serum glucose, total cholesterol (TC) and triglyceride (TG) levels. Adipocyte size significantly decreased with IF, then the number of adipocytes per square millimeter significantly increased (<italic>P</italic> &#x0003C; 0.05). Compared to the C group, the M and MF groups had significantly higher serum melatonin levels (17 and 21%, respectively), although melatonin monotherapy had no effect on serum parameters and adipocytes. There was no interaction between IF and melatonin on BW gain and serum parameters except for on adipocyte area and number per square millimeter, <italic>Bacteroidetes</italic> and <italic>Akkermansia</italic> bacterial abundance, and the levels of the intestinal metabolites alanine, valine and isoleucine. IF changed the intestinal microbiota structure, with the F and MF groups clearly separating from the C and M groups. Metabolomic analysis showed that there was obvious separation between all four groups.</p>
<p><bold>Conclusions:</bold> IF, but neither melatonin nor the interaction between IF and melatonin, could alter intestinal microbiota and metabolism and prevent obesity by reducing BW gain, serum glucose, TC, and TG, and adipocyte size in mice.</p></abstract>
<kwd-group>
<kwd>intermittent fasting</kwd>
<kwd>melatonin</kwd>
<kwd>liver</kwd>
<kwd>intestinal morphology</kwd>
<kwd>gut microbiota</kwd>
<kwd>metabolites</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="14"/>
<word-count count="8566"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Agricultural developments and improve living standards have contributed to a rise in obesity. Obesity has a physiologic influence on organs such as the liver, visceral fat, and the circulatory system (<xref ref-type="bibr" rid="B1">1</xref>). It increases the risk of diseases such as diabetes mellitus (<xref ref-type="bibr" rid="B2">2</xref>), cardiovascular disease (<xref ref-type="bibr" rid="B2">2</xref>), and several types of cancers (<xref ref-type="bibr" rid="B3">3</xref>). Imbalance between energy intake and expenditure is the main cause of obesity (<xref ref-type="bibr" rid="B4">4</xref>). Intermittent fasting (IF) is a dietary energy restriction method that reduces energy intake and thereby reduces obesity. From an evolutionary point of view, fasting is a natural phenomenon that humans and lower organisms were regularly exposed to. Humans, especially in some religious groups (<xref ref-type="bibr" rid="B5">5</xref>), have practiced IF for centuries, and IF has been shown to improve body composition and health (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). IF reduces body weight, fat mass and caloric intake comparable to a low-fat diet, and glucose and insulin tolerance can be altered by IF (<xref ref-type="bibr" rid="B8">8</xref>). Moreover, IF extends overall lifespan and reduces the development of aging-related diseases, including diabetes, cardiovascular disease and neurodegenerative diseases (<xref ref-type="bibr" rid="B9">9</xref>). Previous studies have shown that altering caloric intake or meal timing can delay the occurrence and development of disease and improves the health and lifespan of most organisms (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). The potential physiologic processes involved in IF include periodic changes in the source of metabolic fuel, the promotion of repair mechanisms, and the optimization of healthy energy utilization by cells and body (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Melatonin is a biochemical hormone secreted by the pineal gland that inhibits melanin formation (<xref ref-type="bibr" rid="B13">13</xref>). Melatonin-related enzymes and receptors are found in almost every tissue and cell (<xref ref-type="bibr" rid="B14">14</xref>), suggesting that melatonin has a wide range of functions. As a powerful antioxidant, melatonin can control the survival and differentiation of immune cells, scavenge free radicals, and increase the activity of antioxidant enzymes, thereby reducing inflammation and resisting oxidative stress (<xref ref-type="bibr" rid="B15">15</xref>). Melatonin can also protect the liver from oxidative stress-induced damage (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>Previous studies have shown that melatonin drives the body&#x00027;s energy balance toward reducing food intake, increases energy consumption by burning brown adipose tissue, and prevents excessive weight gain (<xref ref-type="bibr" rid="B17">17</xref>). Melatonin reduced body weight, liver steatosis and low-grade inflammation while improving insulin resistance in high fat diet (HFD)-fed mice (<xref ref-type="bibr" rid="B18">18</xref>). Melatonin levels in the gut are at least 400 times higher than in the pineal gland, and 10&#x02013;100 times higher than in the blood (<xref ref-type="bibr" rid="B19">19</xref>), suggesting that melatonin may play an important role in normal gut function. The role of melatonin in the prevention and treatment of intestinal diseases has been borne out by prior literatures (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Melatonin can also serve as a mediator of microbial metabolism, circadian rhythms, and intestinal mucosal immune cells (<xref ref-type="bibr" rid="B20">20</xref>). Melatonin treatment significantly changed the composition of the gut microbiota in mice fed a HFD (<xref ref-type="bibr" rid="B18">18</xref>). Gut microbiota, directly affects the gastrointestinal (GI) tract, liver, skin, and central nervous system, and participates in the digestion and absorption of nutrients (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Due to the interrelationship between melatonin and the gut microbiota, melatonin has been hypothesized to be involved in communication between the gut tissue and the intestinal microbiota (<xref ref-type="bibr" rid="B15">15</xref>). Gut bacteria has been found to recognize and respond to melatonin signals in the intestine <italic>via</italic> melatonin binding sites (<xref ref-type="bibr" rid="B23">23</xref>), supporting this relationship.</p>
<p>Lots of studies on obese people showed IF benefits for preventing metabolic disorder, however, it is deserved to find what effects IF may exert on metabolism of people on a popular normal diet. Melatonin, as a hormone regulating circadian rhythm, can also affect body weight gain and intestinal microbiota. It is interesting to explore if the interaction exits between the IF and melatonin. This study aimed to investigate the potential interaction of IF and oral melatonin on body weight, blood indices, intestinal and liver morphology, and intestinal microbiota and metabolites in an experimental mouse model.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title>Animals and Experimental Design</title>
<p>Male C57BL/6J mice (23.0 &#x000B1; 0.9 g, 6 weeks of age) were obtained from Shanghai SLAC Laboratory Animal Co., Ltd (Shanghai, China). All animals were maintained under standardized conditions (23 &#x000B1; 1&#x000B0;C; 12-h light-dark cycle). All animal procedures were performed in full accordance with the &#x0201C;Regulation for the Use of Experimental Animals&#x0201D; of Zhejiang Province, China. This study was specifically approved by the Animal Care and Use Committee of Zhejiang University (ETHICS CODE Permit no. ZJU20170529). Animals were fed commercial feed (&#x00023;P1101F, Slacom, Shanghai, China) composed of fish meal, wheat, corn, soybean meal, wheat bran, vitamin, mineral and amino acids that contained at least 20.5% crude protein, 4% crude fat, 1.32% lysine, and 0.78% methionine &#x0002B; cystine, and &#x02264; 5% crude fiber, and &#x02264; 8% crude ash. After acclimatization for 10 days, mice were randomly assigned into four groups (12 mice/group): control (C), intermittent fasting (F), melatonin (M), and intermittent fasting plus melatonin (MF). The C and M groups mice were provided with <italic>ad libitum</italic> access to food and water, while the F and MF groups underwent alternative-day feed deprivation (15 cycles total). Melatonin was administered in the drinking water of the M and MF groups. Due to the experimental design, we are not able to determine the melatonin intake for each mouse; instead, melatonin was titrated to an averaged dose of 10 mg/kg body weight and provided in the drinking water. The melatonin water was prepared daily and kept in a normal bottle with an aluminum foil cover to prevent light-induced melatonin degradation.</p>
<p>Body weight and food/water intake were measured daily. The mice were euthanized at the end of the trial with an intraperitoneal injection of pentobarbital sodium (50 mg/kg body weight), and blood and tissue samples were collected.</p>
</sec>
<sec>
<title>Serum Biochemical Analysis</title>
<p>Blood samples were centrifuged at 3,000 &#x000D7; g for 10 min at 4&#x000B0;C to produce serum samples. The levels of serum glucose, triglyceride (TG), total cholesterol (TC), low density lipoproteins cholesterol (LDL-C), and high density lipoproteins cholesterol (HDL-C) were quantified using corresponding ELISA kits (no. F006, no. A110-1, no. A111-1, no. A113-1, and no. A112-1, respectively; Nanjing Jiancheng Bioengineering Institution, Nanjing, China). Serum levels of alanine aminotransferase (ALT) (no. C009) and aspartate aminotransferase (AST) (no. C010) were measured using kinetics-based assays with commercially available kits (Nanjing Jiancheng Bioengineering Institution, Nanjing, China) and an automatic biochemistry analyzer (SELECTA XL; Vital Scientific, Newton, MA, USA) according to protocols provided by the manufacturers. Serum melatonin and insulin levels were measured using ELISA kits (no. H256-1-2 and no. H203-1-2, respectively; Nanjing Jiancheng Bioengineering Institution, Nanjing, China).</p>
</sec>
<sec>
<title>Hematoxylin-Eosin (H&#x00026;E) Staining</title>
<p>H&#x00026;E staining was performed as previously described (<xref ref-type="bibr" rid="B24">24</xref>). Epididymal adipose, liver, ileal, and colonic samples were fixed, dehydrated, and paraffin embedded. The sections were prepared and subsequently stained with H&#x00026;E. Photomicrographs were obtained using an optical microscopy system (Olympus Corporation, Tokyo, Japan). Quantitative measurement of adipocyte count, ileal villi height, ileal crypt depth, and colonic fold height were conducted with ImageJ (National Institutes of Health, Bethesda, MD, USA). Adipocytes area was calculated using at least three histological sections and a total of 300 adipocytes per mouse. A pathologist evaluated the liver slides.</p>
</sec>
<sec>
<title>Transmission Electron Microscopy (TEM)</title>
<p>TEM of liver tissues was performed as previously described (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). The specimen was sectioned using a LEICA EM UC7 ultratome, and sections were stained with uranyl acetate and alkaline lead citrate. Section were visualized with a Hitachi H-7650 TEM.</p>
</sec>
<sec>
<title>16S rDNA Gene Analysis</title>
<p>The entire intestinal contents were collected and used for bacterial 16S rDNA sequencing. High-resolution 16S rDNA genes of the intestinal bacterial flora were analyzed using a previously described method with modifications (<xref ref-type="bibr" rid="B27">27</xref>). DNA was extracted from the intestinal contents using the Qiagen DNA Kit (51640, Germany) according to the manufacturer&#x00027;s instructions. The selected region of 16S rDNA amplification was the V3&#x02013;V4 region PCR products were quantified using Qubit (Invitrogen, USA). An Illumina NovaSeq PE250 (Illumina, San Diego, USA) was used for on-board sequencing, followed by bioinformatics analysis. Chimeric sequence detection and <italic>de novo</italic> operational taxonomic units (OTU) picked up with 0.97 identities were performed using Usearch (version 7.0) and UPARSE (<ext-link ext-link-type="uri" xlink:href="http://drive5.com/uparse/">http://drive5.com/uparse/</ext-link>), respectively (<xref ref-type="bibr" rid="B28">28</xref>). Alpha/beta diversity and the relative abundance of bacteria at the phylum and genus level were analyzed with QIIME1 (V1.9.1). Principal coordinates analysis (PCoA) of Weighted-Unifrac distance was used to visualize the bacteria communities of each of the four groups. PICRUSt was used to predict the functional composition of the metagenome, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology functional database was used as reference for this prediction (<xref ref-type="bibr" rid="B29">29</xref>). Linear discriminant analysis (LDA) effect size (LEfSe) was used to estimate the effect of each component metabolic pathway on the difference, and to find out the metabolic pathway that had a significant difference on the sample division (The default screening condition is LDA &#x0003E;2).</p>
</sec>
<sec>
<title>Metabolomic Analysis</title>
<p>About 50 mg sample with 500 &#x003BC;L pre-cold extraction mixture [methanol/chloroform (v:v) = 3:1] and 10 &#x003BC;L internal standard (L-2-Chlorophenylalanine, 1 mg/mL stock) were added into a 2 mL tube. Then the sample was vortexed for 30 s and homogenized with ball mill for 4 min at 35 Hz, followed by ultrasonication for 5 min on ice water. The mixture was extracted and centrifuged at 13,300 &#x000D7; g for 15 min at 4&#x000B0;C. Supernatant was collected and analyzed using gas chromatography coupled with a time-of-flight mass spectrometer (GC-TOF-MS) according to a previous method (<xref ref-type="bibr" rid="B30">30</xref>), which did not distinguish between positive and negative, and the results did not distinguish between polarity and non-polarity. The LECO-Fiehn Rtx5 database was used to identify metabolites by matching the mass spectrum and the retention index (<xref ref-type="bibr" rid="B31">31</xref>). Peaks detected in less than half of the QC samples or with a RSD &#x0003E;30% in the QC samples was removed (<xref ref-type="bibr" rid="B32">32</xref>). Follow-up analysis of the obtained data was performed using existing methods (<xref ref-type="bibr" rid="B33">33</xref>). The final dataset containing the information of peak number, sample name and normalized peak area was imported into MetaboAnalyst 4.0 (<ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca/">https://www.metaboanalyst.ca/</ext-link>) for multivariate analysis. Partial least squares discrimination analysis (PLS-DA) and <italic>t</italic>-test were performed between the two groups, with a false discovery rate (FDR) adjusted <italic>P</italic> &#x0003C; 0.05 and variable importance in projection (VIP) &#x0003E; 1.5 used to identify a significant different in metabolites. Commercial databases including KEGG (<ext-link ext-link-type="uri" xlink:href="http://www.genome.jp/kegg/">http://www.genome.jp/kegg/</ext-link>) were used for pathway enrichment analysis.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Statistical analysis was performed using SAS software (SAS9.04, Cary NC, USA). All data are presented as mean &#x000B1; standard error (SE). Significant differences were identified using 2-factor ANOVAs with a general linear model for this 2 x 2 factorial experiment and IF x melatonin interaction was tested, followed by Duncan&#x00027;s multiple range tests. A <italic>P</italic>-value of &#x0003C;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Growth Performance</title>
<p>Compared with the C group, IF and melatonin did not affect cumulative food intake (<xref ref-type="fig" rid="F1">Figure 1A</xref>). However, IF (F and MF) led to significantly lower BW (<xref ref-type="fig" rid="F1">Figure 1B</xref>) and significantly lower BW gain (50 and 64% lower than C, respectively, <xref ref-type="fig" rid="F1">Figure 1C</xref>). Food intake after fasting for 24 h sharply increased (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1A</xref>). When the mice fasted, their water intake was also lower than normal (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1B</xref>). The average dose of melatonin over the study period was shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1C</xref> (one cycle means a non-fasting day and a fasting day), and confirms that the average daily melatonin intake was close to 10 mg/kg. In addition, epididymal fat mass in the F and MF groups was significantly lower than in the C group (25 and 30%, respectively; <xref ref-type="fig" rid="F1">Figure 1D</xref>). Melatonin alone, and the use of melatonin with fasting did not have a significant impact on BW and epididymal fat mass (<italic>P</italic> &#x0003E; 0.05).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on food intake and body weight gain in mice. <bold>(A)</bold> Cumulative food intake. <bold>(B)</bold> Body weight. <bold>(C)</bold> Weight gain after treatment for 30 days. <bold>(D)</bold> Epididymal fat mass of mice at the end of the experiment. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Serum Indices</title>
<p>The F and MF groups had significantly lower serum glucose (66 and 61% lower, respectively, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2A</xref>), TC (29 and 26% lower, respectively, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2B</xref>) and TG (31 and 34% lower, respectively, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2C</xref>) levels than the C group. There was no significant difference in serum glucose, TC, or TG between the M and C groups, or between the MF and F groups. However, the MF group had significantly lower serum glucose (61% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2A</xref>), TC (19% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2B</xref>) and TG (27% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2C</xref>) than the M group. Compared with the C group, MF group mice had significantly lower serum LDL-C (25% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2D</xref>). No significant difference was observed in serum HDL-C (<xref ref-type="fig" rid="F2">Figure 2E</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on serum indexes in mice. <bold>(A)</bold> Glucose; <bold>(B)</bold> TC; <bold>(C)</bold> TG; <bold>(D)</bold> LDL-C; <bold>(E)</bold> HDL-C; <bold>(F)</bold> Insulin; <bold>(G)</bold> Melatonin; <bold>(H)</bold> ALT; <bold>(I)</bold> AST. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 8&#x0007E;12. Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking. ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL-C, high density lipoproteins cholesterol; LDL-C, low density lipoproteins cholesterol; TC, total cholesterol; TG, triglyceride.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0002.tif"/>
</fig>
<p>Serum insulin level was significantly lower in the F (36% lower) and MF (35% lower) groups than the M group (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2F</xref>). Serum melatonin level was significantly higher in the M and MF group than in the C (17 and 21% higher, respectively, <italic>P</italic> &#x0003C; 0.05) and F (9 and 13% higher, respectively, <italic>P</italic> &#x0003C; 0.05) groups (<xref ref-type="fig" rid="F2">Figure 2G</xref>). Compared with the C group, the F group had significantly lower serum ALT (37% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2H</xref>) and AST (32% lower, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F2">Figure 2I</xref>), whereas the MF group had significantly lower serum AST (41% lower, <italic>P</italic> &#x0003C; 0.05) and an equivalent serum ALT. There was little interaction between IF and melatonin in serum parameters (<italic>P</italic> &#x0003E; 0.05).</p>
</sec>
<sec>
<title>Intestinal Morphology</title>
<p>The morphology of ileal and colonic tissues was visualized with H&#x00026;E staining and shown in <xref ref-type="supplementary-material" rid="SM2">Supplementary Figures 2A,B</xref>, respectively. Compared with the C group, the F group mice had significantly higher villus height (13% increase, <italic>P</italic> &#x0003C; 0.05) and villus height/crypt depth ratio (20% increase, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 2C</xref>). The villus height/crypt depth of the MF group was also significantly higher than that of the C group (15% increase, <italic>P</italic> &#x0003C; 0.05). There were no significant differences in ileal crypt depth identified. There were no significant differences in colonic fold length between groups (<italic>P</italic> &#x0003E; 0.05, <xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 2D</xref>). No significant interaction between IF and melatonin was found on villus height, crypt depth and colonic fold length (<italic>P</italic> &#x0003E; 0.05).</p>
</sec>
<sec>
<title>Adipocyte Morphology in Epididymal White Adipose Tissue</title>
<p>Histologic analysis of the epididymal white adipose tissue (eWAT) revealed an increase in the number of multilobular adipocytes in IF mice (<xref ref-type="fig" rid="F3">Figure 3A</xref>), a typical characteristic of beige adipocytes. F and MF group mice had a significantly smaller adipocyte size (37 and 20% decrease, respectively, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F3">Figure 3B</xref>), but a significant increase in adipocyte number per square millimeter (78 and 32% increase, respectively, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F3">Figure 3C</xref>), compared with the corresponding non-fasting group (C and M, respectively). M group mice had a significantly higher number of adipocytes per square millimeter than C group mice (30% increase, <italic>P</italic> &#x0003C; 0.05). The interaction between fasting and melatonin had significant effects on adipocytes size and number (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F3">Figures 3B,C</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on adipocytes morphology in mice. <bold>(A)</bold> Representative H&#x00026;E staining of epididymal WAT sections. Scale bar: 50 &#x003BC;m; <bold>(B)</bold> quantification of adipocyte size; <bold>(C)</bold> quantification of adipocyte number per square millimeter. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 6. Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Morphologic Structure of Liver Tissue</title>
<p>Liver tissue morphology was normal in all groups, without obvious signs of inflammation or lesions (<xref ref-type="fig" rid="F4">Figure 4</xref>). However, sections of the liver assessed with TEM showed a greater number of lipid droplets in the fasting groups (F and MF) compared with the C and M groups (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Representative H&#x00026;E samples showing differences in liver morphology in control mice vs. those with intermittent fasting and/or melatonin treatment. Scale bar: 50 &#x003BC;m. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0004.tif"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Representative TEM images depicting the number of lipid droplets in the livers of control mice vs. those with intermittent fasting and/or melatonin treatment. Scale bar: 5 &#x003BC;m. Images of the fasting groups (F and MF) revealed a great number of lipid droplets (white arrows). C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. TEM, Transmission electron microscopy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0005.tif"/>
</fig>
</sec>
<sec>
<title>Analysis of Intestinal Microbiota</title>
<p>The rarefaction curve of observed species (<xref ref-type="supplementary-material" rid="SM3">Supplementary Figure 3A</xref>) and Chao 1 index (<xref ref-type="supplementary-material" rid="SM3">Supplementary Figure 3B</xref>) of gut microbiota plateaued when the read increased to a certain level. The F and M groups had significantly lower alpha diversity (7.7 and 8.7% lower, respectively, <italic>P</italic> &#x0003C; 0.05) than the MF group (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Adonis analysis showed no noticeable separation between the M and C groups (<xref ref-type="fig" rid="F6">Figure 6B</xref>). However, the fasting groups (F and MF) were clearly separated from the C and M groups (<xref ref-type="fig" rid="F6">Figure 6B</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on intestinal microbiota in mice. <bold>(A)</bold> Differences in the &#x003B1; diversity index between groups (Chao 1 diversity index); <bold>(B)</bold> principal Coordinates Analysis (PCoA) of intestinal microbiota (&#x003B2; diversity); <bold>(C)</bold> LEfSe (LDA Effect Size) analysis of KEGG pathway enrichment in different groups, <italic>n</italic> = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05). C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0006.tif"/>
</fig>
<p>LEfSe analysis showed the following metabolic pathway (LDA &#x0003E;2) between each group: secretion system, biosynthesis of unsaturated fatty acid for the F group; phosphotransferase system and other ion coupled transporters for the MF group; membrane and intracellular structural molecules and the citrate cycle TCA cycle for the M group (<xref ref-type="fig" rid="F6">Figure 6C</xref>).</p>
<p>There were 32 genera of intestinal flora that were significantly different between the groups. The 6 genera with the most significant difference were shown in <xref ref-type="fig" rid="F7">Figures 7A&#x02013;F</xref>. Compared with the C group, the F group exhibited a significant increase in the abundance of <italic>Lactobacillus</italic> (fold change, FC = 28.87, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7A</xref>), <italic>Ruminococcus</italic> (FC = 12.21, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7B</xref>) and <italic>Akkermansia</italic> (FC = 24.19, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7C</xref>) and significantly lower abundance of <italic>Helicobacter</italic> (FC = 0.34, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7D</xref>), <italic>Prevotella</italic> (FC = 0.05, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7E</xref>) and <italic>Parasutterella</italic> (FC = 0.31, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7F</xref>). Compared with the C group, the M group had a significantly lower abundance of <italic>Prevotella</italic> (FC = 0.67, <italic>P</italic> &#x0003C; 0.05, <xref ref-type="fig" rid="F7">Figure 7E</xref>). In addition, the interaction between fasting and melatonin had a significant effect on the abundance of <italic>Akkermansia</italic> (<italic>P</italic> &#x0003C; 0.01). Relative abundance by phylum is shown in <xref ref-type="supplementary-material" rid="SM3">Supplementary Figure 3C</xref>. IF but not melatonin had significant effects on intestinal <italic>Firmicute, Bacteroides</italic> and the radio of <italic>Firmicutes/Bacteroides</italic> (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM3">Supplementary Figures 3D&#x02013;F</xref>). In addition, the interaction between fasting and melatonin had a significant effect on the relative abundance of intestinal <italic>Firmicute</italic> and <italic>Bacteroides</italic> (<italic>P</italic> &#x0003C; 0.05).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on intestinal microbiota at the genus level in mice. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking. The relative abundance of <italic>Lactobacillus</italic> <bold>(A)</bold>, <italic>Ruminococcus</italic> <bold>(B)</bold>, <italic>Akkermansia</italic> <bold>(C)</bold>, <italic>Helicobacter</italic> <bold>(D)</bold>, <italic>Prevotella</italic> <bold>(E)</bold>, and <italic>Parasutterella</italic> <bold>(F)</bold> in mice.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0007.tif"/>
</fig>
</sec>
<sec>
<title>Metabolomic Analysis of Intestinal Contents</title>
<p>The partial least-squares discriminate analysis (PLS-DA) scores plot showed a clear separation between all treatments (<xref ref-type="fig" rid="F8">Figure 8A</xref>). And the permutation test was evaluated based on the corresponding PLS-DA model (<xref ref-type="fig" rid="F8">Figure 8B</xref>). A total of 482 metabolites were detected by metabolomics (<xref ref-type="supplementary-material" rid="SM6">Supplementary Table 1</xref>) and the top 19 metabolites with the highest abundance were shown in <xref ref-type="fig" rid="F8">Figure 8C</xref>. Differences in metabolites between groups were shown in <xref ref-type="supplementary-material" rid="SM4">Supplementary Figure 4</xref>. Fasting significantly decreased glucose abundance (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM4">Supplementary Figure 4A</xref>) but increased ribose, alanine, glycine, valine, isoleucine, tyrosine and 2-ketoadipate abundance (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM4">Supplementary Figures 4B&#x02013;H</xref>). Melatonin alone had a significant effect on 2-ketoadipate abundance (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM4">Supplementary Figure 4H</xref>). The interaction between fasting and melatonin had significant effects on alanine, valine and isoleucine abundances (<italic>P</italic> &#x0003C; 0.05, <xref ref-type="supplementary-material" rid="SM4">Supplementary Figures 4C,E,F</xref>).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on intestinal metabolites in mice. <bold>(A)</bold> Score plot from and PLS-DA of metabolite profiles of the intestinal contents of mice between all groups. Each data point represents a function of the entire spectral profile of each subject; <bold>(B)</bold> The permutation test was evaluated based on the corresponding PLS-DA model. <bold>(C)</bold> A heatmap of significantly altered metabolites in the intestines of mice between all groups. <bold>(D)</bold> Metabolic pathways related to each metabolite. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 12. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0008.tif"/>
</fig>
<p>The KEGG enrichment pathways of different metabolites were further analyzed (<xref ref-type="fig" rid="F8">Figure 8D</xref>). The main enrichment pathways were: galactose metabolism; starch and sucrose metabolism, alanine, aspartate and glutamate metabolism, glycolysis or gluconeogenesis, aminoacyl-tRNA biosynthesis and the synthesis and degradation of ketone bodies. Metabolites related to butyric acid metabolism including 4-hydroxybutyrate and 3-hydroxybutyric acid are shown in <xref ref-type="fig" rid="F9">Figures 9A,B</xref>. Fasting had a significant effect on intestinal 4-hydroxybutyrate (<xref ref-type="fig" rid="F9">Figure 9A</xref>) and 3-hydroxybutyric acid (<xref ref-type="fig" rid="F9">Figure 9B</xref>) (<italic>P</italic> &#x0003C; 0.05).</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p>Significantly altered intestinal metabolites between in control mice and those treated with intermittent fasting and melatonin. <bold>(A)</bold> 4-hydroxybutyrate abundance. <bold>(B)</bold> 3-hydroxybutyric acid abundance. Data are presented as mean &#x000B1; SEM, n = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnut-08-784681-g0009.tif"/>
</fig>
</sec>
<sec>
<title>Correlation Analysis of Phenotype, Bacteria, and Metabolites</title>
<p>We analyzed correlations between the phenotype and the differences of gut microbita or metabolome (<xref ref-type="supplementary-material" rid="SM5">Supplementary Figure 5A</xref>). Serum glucose and TC levels were positively correlated with the <italic>Prevotella</italic> abundance. The epididymal fat mass and serum glucose level were negatively correlated with the metabolites alanine, isoleucine and methionine.</p>
<p>We also analyzed correlations between differential bacteria (genus) and metabolites (<xref ref-type="supplementary-material" rid="SM5">Supplementary Figure 5B</xref>). Bacteria from genera <italic>Lactobacillus, Olsenella, Desulfovibrio</italic>, and <italic>Parvibacter</italic> were positively correlated with the metabolites ribose, 3-hydroxybutyric acid, and the amino acids methionine, alanine, isoleucine and valine. However, these metabolites were negatively correlated with the genera <italic>Prevotella, Parasutterella, Parabacteroides, Helicobacter, Paraprevotella, Barnesiella</italic>, and <italic>Vampirovibrio</italic>.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study, IF significantly reduced BW of mice, although there was no significant difference in cumulative food intake. IF reduced BW, fat mass, and caloric intake in a manner comparable with a low fat diet (<xref ref-type="bibr" rid="B8">8</xref>), suggesting that IF reduces the BW of both obese and normal hosts. A study on IF in obese patients found that weight loss occurs over several weeks because, despite overeating on refeeding days, individuals do not fully compensate for the calorie-deficit realized on fasting days (<xref ref-type="bibr" rid="B34">34</xref>). This was similar to what was recorded in our mice model after 24 h of fasting. These effects were in part due to the shift from the utilization of glucose to fatty acids and ketones as the body&#x00027;s preferred fuel source during fasting (<xref ref-type="bibr" rid="B35">35</xref>). As shown in this study, fasting groups (F and MF) had a significantly lower serum glucose level, ribose level, and intestinal glucose abundance but significantly higher gut 2-ketoadipate abundance than the C and M groups. Food and water intake in mice seems to follow a pattern of small, frequent meals associated with drinking (<xref ref-type="bibr" rid="B36">36</xref>). When the mice were deprived of food on fasting days, they drank significantly less water as well (<xref ref-type="bibr" rid="B37">37</xref>). As a result, water intake fluctuated with food intake during fasting.</p>
<p>The morphologic observations of eWAT in the present work demonstrated that fasting resulted in reduced adipocyte area. The number of multilobular adipocytes was significant increased by IF, which is a typical characteristic of beige adipocytes. These results indicate that eWAT browning occurs during fasting. This is consistent with previous reports that found that fasting caused WAT browning in mice, and that IF increased energy expenditure through non-shivering thermogenesis (<xref ref-type="bibr" rid="B38">38</xref>). Melatonin was found to directly regulates energy consumption by activating brown adipose tissue and participating in the browning process of WAT (<xref ref-type="bibr" rid="B39">39</xref>). Melatonin had a significant effect on the number of adipocytes per square millimeter in the present work, but no effect on adipocyte size.</p>
<p>Several studies have shown that melatonin prevents obesity in different animal models (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>) and has a protective effect against dietary-induced obesity (<xref ref-type="bibr" rid="B18">18</xref>). In this study, oral administration of melatonin through the drinking water improved serum melatonin level but had no effect on body weight gain and serum indexes of mice fed on normal diet. The level of serum melatonin was positively correlated with the abundance of <italic>Allobaculum</italic>, indicating that the addition of exogenous melatonin may affect the content of <italic>Allobaclum</italic> in the intestine.</p>
<p>Intestinal morphology can be used to assess intestine function and health (<xref ref-type="bibr" rid="B42">42</xref>). The long villi and shallow crypts of the ileum are associated with digestive and absorptive function (<xref ref-type="bibr" rid="B43">43</xref>). In this study, the F group had significantly greater ileal villi length and villi length/crypt depth than the C group, indicating that the ileal villi became longer and the crypts became shallower to enhance the digestive and absorptive capacity of the small intestine in order to adapt to the relative lack of nutrition under fasting conditions.</p>
<p>Fasting was able to induce the accumulation of lipid droplets all over cells (<xref ref-type="bibr" rid="B44">44</xref>). Lipid droplets rich in triglycerides are efficiently decomposed in hepatocytes to provide fatty acids for the formation of lipoprotein particles (<xref ref-type="bibr" rid="B45">45</xref>). In this study, fasting may lead to the influx of fatty acids from adipose tissue into the liver to a certain extent, thereby increasing the number of lipid droplets in the liver.</p>
<p>Studies on obese mice have shown that the obese microbiome has an increased capacity to harvest energy from the diet (<xref ref-type="bibr" rid="B46">46</xref>). The obese mice fed with HFD had significantly higher <italic>Firmicutes</italic> but lower <italic>Bacteroides</italic> relative abundance in caecum (<xref ref-type="bibr" rid="B47">47</xref>). In this study, IF changed the gut microbiota, with an increased abundance of <italic>Firmicutes</italic> but a decreased abundance of <italic>Bacteroides</italic>, which eventually led to dramatic changes in microbiota composition and an increased <italic>Firmicutes/Bacteroidetes</italic> ratio. It indicated that IF changed the intestinal microbiota of mice and led them similar to obesity, that is to say, IF increased the ability of intestinal microbiota to obtain energy from diet. This finding are consistent with the results of previous study (<xref ref-type="bibr" rid="B38">38</xref>). Similar shifts in <italic>Firmicutes/Bacteroidetes</italic> ratio in mice were found to be associated with enhanced energy extraction during cold stress and increased glucose uptake in inguinal WAT (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>The vast majority of butyrate-producing bacteria in the gut is <italic>Firmicutes</italic> (<xref ref-type="bibr" rid="B49">49</xref>), and butyric acid absorbed by the colonic mucosa is the preferred energy source for colonocytes (<xref ref-type="bibr" rid="B50">50</xref>). Metabonomic analysis of intestinal contents showed that fasting increased the 3-hydroxybutyric acid and 4-hydroxybutyric acid content, which may correspond with changes in microorganisms.</p>
<p>IF increased the abundance of lactic acid bacteria. <italic>Lactobacillus</italic> has the ability to digest nutrients and may have a significant influence on carbohydrate metabolism (<xref ref-type="bibr" rid="B51">51</xref>). This study showed that the abundance of intestinal <italic>Lactobacillus</italic> was negatively correlated with serum glucose level, TC and body weight gain. And the abundance of <italic>Lactobacillus</italic> was positively correlated with the contents of various metabolites (3-hydroxybutyric acid, ribose, 3, 7, 12-trihydroxycoprostane). IF induced enrichment of <italic>Lactobacilli</italic>, which are commonly used as probiotics because of their beneficial effects, including reduction of inflammatory immune responses (<xref ref-type="bibr" rid="B52">52</xref>). <italic>Akkermansia</italic> also increased under fasting conditions in this study. <italic>A. muciniphila</italic> not only participates in the host immune regulation, but also enhances the integrity of the intestinal epithelial cells and the thickness of the mucus layer, thereby promoting intestinal health (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>). In this study, fasting led to a significantly higher abundance of <italic>Akkermansia</italic> in the gut of mice compared with un-fasting treatment (the C and M group), which indicating that the nutritional supply of the host could affect the growth of <italic>A. muciniphila</italic> in the intestine. When the host is under the fasting or in malnutrition, <italic>A. muciniphila</italic> revealing the characteristics of degrading mucin can be defined as a competitive advantage, which was consistent with the experiment on hamsters that the abundance of <italic>A. muciniphila</italic> significantly increased after fasting (<xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>In the metagenomic analysis, the ketone pathway was enhanced in the gut microbiome of IF mice, which suggests that the gut microbiome regulates its own ketone body metabolism during fasting of the host (<xref ref-type="bibr" rid="B56">56</xref>). Ketones are the preferred fuel for the brain and body during fasting, so the body prioritizes ketones that are converted from the glycogen decomposition of glucose to fatty acids (<xref ref-type="bibr" rid="B57">57</xref>). Fasting increased the abundance of 2-ketoadipate in the intestine in the present work, and metabolites related to the synthesis and degradation of ketone bodies were significantly increased. This shift indicates that the body has shifted from lipid synthesis and fat storage to mobilizing fat in the form of free fatty acids and fatty acid-derived ketones (<xref ref-type="bibr" rid="B35">35</xref>). We found that fasting changed the energy intake pattern in mice, which led to changes in metabolism. Metabonomic analysis of mice intestinal contents showed that the metabolic changes caused by IF were mainly reflected by the relative levels of sugars, amino acids and fatty acids.</p>
<p>In conclusion, IF reduced BW gain, serum glucose, TC, TG, insulin level, and adipocyte size, then increased the number of adipocyte per square millimeter. IF also resulted in increased ileal villus height to optimize digestion and absorption, thereby modulating the intestinal microbiota and metabolites. Melatonin alone had no effect, and there was little interaction between IF and melatonin except for their effects on adipocyte area and number, the abundance of <italic>Bacteroidetes</italic> and <italic>Akkermansia</italic>, and the intestinal metabolites alanine, valine and isoleucine. These results indicate that IF may alter metabolism, reduce obesity and improve intestinal health.</p>
</sec>
<sec sec-type="data-availability" id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found at: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>, PRJNA766780.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Animal Care and Use Committee of Zhejiang University (ETHICS CODE Permit No. ZJU20170529).</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>HW designed the experiments. JinL, YZ, and YM performed the experiments. JinL, HW, and YZ analyzed the data. HW, JinL, XL, and JiaL wrote and revised the main manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The study was supported by grants from the Natural Science Foundation of Zhejiang Province (Z19C170001), the National Natural Science Foundation of China (31672430), the Funds of Ten Thousand People Plan of China and the National Key Research and Development Program of China (2017YFD0500502).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack><p>We would like to thank Shanghai RealBio Biotechnology Co., Ltd and Biotree Biotechnology Co., Ltd for help with 16r DNA sequencing and metabolomic analysis, respectively.</p>
</ack>
<sec sec-type="supplementary-material" id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnut.2021.784681/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnut.2021.784681/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.tif" id="SM1" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 1</label>
<caption><p>Changes in the food, water, and melatonin intake of mice treated with intermittent fasting and melatonin. <italic>n</italic> = 12. (1C) The abscissa indicates that a non-fasting and fasting day is a cycle. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking. Black arrows indicate fasting days.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image_2.tif" id="SM2" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 2</label>
<caption><p>Villus height and crypt depth of the ilea and the colonic folds of colon in control mice and those treated with intermittent fasting and melatonin. <bold>(A)</bold> Representative H&#x00026;E staining of ileum sections. Scale bar: 50 &#x003BC;m; <bold>(B)</bold> representative H&#x00026;E staining of colon sections. Scale bar: 100 &#x003BC;m; <bold>(C)</bold> Villus height, crypt depth and villus/crypt ratio of ileum between groups; <bold>(D)</bold> Colonic folds between groups. Villus height, crypt depth and the length of colonic fold were measured as indicated in the image. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 6; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption> </supplementary-material>
<supplementary-material xlink:href="Image_3.tif" id="SM3" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 3</label>
<caption><p>The effects of intermittent fasting and melatonin supplementation on intestinal microbiota of mice. <bold>(A)</bold> The observed species index of gut microbiota in mice. <bold>(B)</bold> The Chao 1 index of gut microbiota in mice. <bold>(C)</bold> Barplot of intestinal bacterial content at the phylum level in each group; <bold>(D)</bold> relative abundance of <italic>Firmicutes</italic> in the intestinal contents of each group; <bold>(E)</bold> relative abundance of <italic>Bacteroides</italic> in the intestinal contents of each group; <bold>(F)</bold> the proportion of <italic>Firmicutes</italic> to <italic>Bacteroides</italic>. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption> </supplementary-material>
<supplementary-material xlink:href="Image_4.tif" id="SM4" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 4</label>
<caption><p>Significantly altered intestinal metabolites between in control mice and those treated with intermittent fasting and melatonin. The contents of glucose <bold>(A)</bold>, ribose <bold>(B)</bold>, alanine <bold>(C)</bold>, glycine <bold>(D)</bold>, valine <bold>(E)</bold>, isoleucine <bold>(F)</bold>, tyrosine <bold>(G)</bold>, and 2-ketoadipate <bold>(H)</bold> in each group are shown. Data are presented as mean &#x000B1; SEM, <italic>n</italic> = 12; Labeled means without a common letter differ (<italic>P</italic> &#x0003C; 0.05), NS: <italic>P</italic> &#x02265; 0.05. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption> </supplementary-material>
<supplementary-material xlink:href="Image_5.tif" id="SM5" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 5</label>
<caption><p>Correlations between the phenotype and the differences of bacteria (genus) or metabolites in the intestine. <bold>(A)</bold> Correlations between the phenotype and the differences of bacteria (genus) and metabolites. <bold>(B)</bold> Correlations between bacteria (genus) and metabolites in the intestine.</p></caption> </supplementary-material>
<supplementary-material xlink:href="Table_1.xlsx" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 1</label>
<caption><p>All the metabolites detected in the intestinal contents in mice. C, control; F, intermittent fasting; M, melatonin; MF, intermittent fasting plus melatonin. The C and M mice were fed <italic>ad libitum</italic>, while the F and MF groups underwent alternative-day feed deprivation. The M and MF groups mice were supplemented with melatonin at a dose of 10 mg/kg body weight by drinking.</p></caption> </supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>KI</given-names></name> <name><surname>Toyoda</surname> <given-names>S</given-names></name> <name><surname>Jojima</surname> <given-names>T</given-names></name> <name><surname>Abe</surname> <given-names>S</given-names></name> <name><surname>Sakuma</surname> <given-names>M</given-names></name> <name><surname>Inoue</surname> <given-names>T</given-names></name></person-group>. <article-title>Time-restricted feeding prevents high-fat and high-cholesterol diet-induced obesity but fails to ameliorate atherosclerosis in apolipoprotein E-knockout mice</article-title>. <source>Exp Anim</source>. (<year>2020</year>) <volume>70</volume>:<fpage>194</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1538/expanim.20-0112</pub-id><pub-id pub-id-type="pmid">33268668</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>GM</given-names></name> <name><surname>Danaei</surname> <given-names>G</given-names></name> <name><surname>Farzadfar</surname> <given-names>F</given-names></name> <name><surname>Stevens</surname> <given-names>GA</given-names></name> <name><surname>Woodward</surname> <given-names>M</given-names></name> <name><surname>Wormser</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e65174</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0065174</pub-id><pub-id pub-id-type="pmid">23935815</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauby-Secretan</surname> <given-names>B</given-names></name> <name><surname>Scoccianti</surname> <given-names>C</given-names></name> <name><surname>Loomis</surname> <given-names>D</given-names></name> <name><surname>Grosse</surname> <given-names>Y</given-names></name> <name><surname>Bianchini</surname> <given-names>F</given-names></name> <name><surname>Straif</surname> <given-names>K</given-names></name></person-group>. <article-title>Body fatness and cancer&#x02014;viewpoint of the IARC working group</article-title>. <source>N Engl J Med.</source> (<year>2016</year>) <volume>375</volume>:<fpage>794</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsr1606602</pub-id><pub-id pub-id-type="pmid">27557308</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>JO</given-names></name> <name><surname>Wyatt</surname> <given-names>HR</given-names></name> <name><surname>Peters</surname> <given-names>JC</given-names></name></person-group>. <article-title>Energy balance and obesity</article-title>. <source>Circulation.</source> (<year>2012</year>) <volume>126</volume>:<fpage>126</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.087213</pub-id><pub-id pub-id-type="pmid">22753534</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname> <given-names>RE</given-names></name> <name><surname>Laughlin</surname> <given-names>GA</given-names></name> <name><surname>LaCroix</surname> <given-names>AZ</given-names></name> <name><surname>Hartman</surname> <given-names>SJ</given-names></name> <name><surname>Natarajan</surname> <given-names>L</given-names></name> <name><surname>Senger</surname> <given-names>CM</given-names></name> <etal/></person-group>. <article-title>Intermittent fasting and human metabolic health</article-title>. <source>J Acad Nutr Diet.</source> (<year>2015</year>) <volume>115</volume>:<fpage>1203</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.jand.2015.02.018</pub-id><pub-id pub-id-type="pmid">25857868</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eshghinia</surname> <given-names>S</given-names></name> <name><surname>Mohammadzadeh</surname> <given-names>F</given-names></name></person-group>. <article-title>The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women</article-title>. <source>J Diabetes Metab Disord</source>. (<year>2013</year>) <volume>12</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/2251-6581-12-4</pub-id><pub-id pub-id-type="pmid">23497604</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Bueno</surname> <given-names>M</given-names></name> <name><surname>Gonzalez-Jimenez</surname> <given-names>E</given-names></name> <name><surname>Navarro-Prado</surname> <given-names>S</given-names></name> <name><surname>Montero-Alonso</surname> <given-names>MA</given-names></name> <name><surname>Schmidt-RioValle</surname> <given-names>J</given-names></name></person-group>. <article-title>Influence of age and religious fasting on the body composition of Muslim women living in a westernized context</article-title>. <source>Nutr Hosp.</source> (<year>2014</year>) <volume>31</volume>:<fpage>1067</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.3305/nh.2015.31.3.8278</pub-id><pub-id pub-id-type="pmid">25726194</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotthardt</surname> <given-names>JD</given-names></name> <name><surname>Verpeut</surname> <given-names>JL</given-names></name> <name><surname>Yeomans</surname> <given-names>BL</given-names></name> <name><surname>Yang</surname> <given-names>JA</given-names></name> <name><surname>Yasrebi</surname> <given-names>A</given-names></name> <name><surname>Roepke</surname> <given-names>TA</given-names></name> <etal/></person-group>. <article-title>Intermittent fasting promotes fat loss with lean mass retention, increased hypothalamic norepinephrine content, and increased neuropeptide Y gene expression in diet-induced obese male mice</article-title>. <source>Endocrinology.</source> (<year>2016</year>) <volume>157</volume>:<fpage>679</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1210/en.2015-1622</pub-id><pub-id pub-id-type="pmid">26653760</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname> <given-names>MP</given-names></name></person-group>. <article-title>Emerging neuroprotective strategies for Alzheimer&#x00027;s disease: dietary restriction, telomerase activation, and stem cell therapy</article-title>. <source>Exp Gerontol.</source> (<year>2000</year>) <volume>35</volume>:<fpage>489</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/S0531-5565(00)00115-7</pub-id><pub-id pub-id-type="pmid">10959037</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname> <given-names>MP</given-names></name> <name><surname>Allison</surname> <given-names>DB</given-names></name> <name><surname>Fontana</surname> <given-names>L</given-names></name> <name><surname>Harvie</surname> <given-names>M</given-names></name> <name><surname>Longo</surname> <given-names>VD</given-names></name> <name><surname>Malaisse</surname> <given-names>WJ</given-names></name> <etal/></person-group>. <article-title>Meal frequency and timing in health and disease</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2014</year>) <volume>111</volume>:<fpage>16647</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1413965111</pub-id><pub-id pub-id-type="pmid">25404320</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname> <given-names>S</given-names></name></person-group>. <article-title>Circadian physiology of metabolism</article-title>. <source>Science.</source> (<year>2016</year>) <volume>354</volume>:<fpage>1008</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1126/science.aah4967</pub-id><pub-id pub-id-type="pmid">27885007</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrea</surname> <given-names>DF</given-names></name> <name><surname>Clara</surname> <given-names>DG</given-names></name> <name><surname>Michel</surname> <given-names>B</given-names></name> <name><surname>Rafael</surname> <given-names>dC</given-names></name></person-group>. <article-title>A time to fast</article-title>. <source>Science.</source> (<year>2018</year>) <volume>362</volume>:<fpage>770</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.aau2095</pub-id><pub-id pub-id-type="pmid">30442801</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Auld</surname> <given-names>F</given-names></name> <name><surname>Maschauer</surname> <given-names>EL</given-names></name> <name><surname>Morrison</surname> <given-names>I</given-names></name> <name><surname>Skene</surname> <given-names>DJ</given-names></name> <name><surname>Riha</surname> <given-names>RL</given-names></name></person-group>. <article-title>Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders</article-title>. <source>Sleep Med Rev.</source> (<year>2017</year>) <volume>34</volume>:<fpage>10</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.smrv.2016.06.005</pub-id><pub-id pub-id-type="pmid">28648359</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acuna-Castroviejo</surname> <given-names>D</given-names></name> <name><surname>Escames</surname> <given-names>G</given-names></name> <name><surname>Venegas</surname> <given-names>C</given-names></name> <name><surname>Diaz-Casado</surname> <given-names>ME</given-names></name> <name><surname>Lima-Cabello</surname> <given-names>E</given-names></name> <name><surname>Lopez</surname> <given-names>LC</given-names></name> <etal/></person-group>. <article-title>Extrapineal melatonin: sources, regulation, and potential functions</article-title>. <source>Cell Mol Life Sci.</source> (<year>2014</year>) <volume>71</volume>:<fpage>2997</fpage>&#x02013;<lpage>3025</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-014-1579-2</pub-id><pub-id pub-id-type="pmid">24554058</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>N</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name> <name><surname>Ma</surname> <given-names>X</given-names></name></person-group>. <article-title>Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: a therapeutic target to reduce intestinal inflammation</article-title>. <source>Med Res Rev.</source> (<year>2020</year>) <volume>40</volume>:<fpage>606</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/med.21628</pub-id><pub-id pub-id-type="pmid">31420885</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>DX</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Manchester</surname> <given-names>LC</given-names></name> <name><surname>Rosales-Corral</surname> <given-names>SA</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Melatonin in the biliary tract and liver: health implications</article-title>. <source>Curr Pharm Des.</source> (<year>2014</year>) <volume>20</volume>:<fpage>4788</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.2174/1381612819666131119105826</pub-id><pub-id pub-id-type="pmid">24251672</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname> <given-names>FGD</given-names></name> <name><surname>Andrade-Silva</surname> <given-names>J</given-names></name> <name><surname>Kuwabara</surname> <given-names>WMT</given-names></name> <name><surname>Cipolla-Neto</surname> <given-names>J</given-names></name></person-group>. <article-title>New insights into the function of melatonin and its role in metabolic disturbances</article-title>. <source>Expert Rev Endocrinol Metab.</source> (<year>2019</year>) <volume>14</volume>:<fpage>293</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1080/17446651.2019.1631158</pub-id><pub-id pub-id-type="pmid">31192707</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>PF</given-names></name> <name><surname>Wang</surname> <given-names>JL</given-names></name> <name><surname>Hong</surname> <given-names>F</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Jin</surname> <given-names>X</given-names></name> <name><surname>Xue</surname> <given-names>TT</given-names></name> <etal/></person-group>. <article-title>Melatonin prevents obesity through modulation of gut microbiota in mice</article-title>. <source>J Pineal Res.</source> (<year>2017</year>) <volume>62</volume>:<fpage>e12399</fpage>. <pub-id pub-id-type="doi">10.1111/jpi.12399</pub-id><pub-id pub-id-type="pmid">28199741</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huether</surname> <given-names>G</given-names></name></person-group>. <article-title>Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin</article-title>. <source>Ann NY Acad Sci.</source> (<year>1994</year>) <volume>719</volume>:<fpage>146</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1994.tb56826.x</pub-id><pub-id pub-id-type="pmid">8010590</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gil-Martin</surname> <given-names>E</given-names></name> <name><surname>Egea</surname> <given-names>J</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name> <name><surname>Romero</surname> <given-names>A</given-names></name></person-group>. <article-title>The emergence of melatonin in oncology: focus on colorectal cancer</article-title>. <source>Med Res Rev.</source> (<year>2019</year>) <volume>39</volume>:<fpage>2239</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1002/med.21582</pub-id><pub-id pub-id-type="pmid">30950095</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinsen</surname> <given-names>FA</given-names></name> <name><surname>Knecht</surname> <given-names>H</given-names></name> <name><surname>Neulinger</surname> <given-names>SC</given-names></name> <name><surname>Schmitz</surname> <given-names>RA</given-names></name> <name><surname>Knecht</surname> <given-names>C</given-names></name> <name><surname>Kuhbacher</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin</article-title>. <source>Gut Microbes.</source> (<year>2015</year>) <volume>6</volume>:<fpage>243</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2015.1062959</pub-id><pub-id pub-id-type="pmid">26178862</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname> <given-names>P</given-names></name> <name><surname>Kunze</surname> <given-names>WA</given-names></name> <name><surname>Bienenstock</surname> <given-names>J</given-names></name></person-group>. <article-title>On communication between gut microbes and the brain</article-title>. <source>Curr Opin Gastroenterol.</source> (<year>2012</year>) <volume>28</volume>:<fpage>557</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1097/MOG.0b013e3283572ffa</pub-id><pub-id pub-id-type="pmid">23010679</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paulose</surname> <given-names>JK</given-names></name> <name><surname>Cassone</surname> <given-names>VM</given-names></name></person-group>. <article-title>The melatonin-sensitive circadian clock of the enteric bacterium Enterobacter aerogenes</article-title>. <source>Gut Microbes.</source> (<year>2016</year>) <volume>7</volume>:<fpage>424</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2016.1208892</pub-id><pub-id pub-id-type="pmid">27387841</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>CJ</given-names></name> <name><surname>Chiu</surname> <given-names>CC</given-names></name> <name><surname>Chen</surname> <given-names>YC</given-names></name> <name><surname>Chen</surname> <given-names>ML</given-names></name> <name><surname>Hsu</surname> <given-names>TC</given-names></name> <name><surname>Tzang</surname> <given-names>BS</given-names></name></person-group>. <article-title>Taurine attenuates hepatic inflammation in chronic alcohol-fed rats through inhibition of TLR4/MyD88 signaling</article-title>. <source>J Med Food.</source> (<year>2015</year>) <volume>18</volume>:<fpage>1291</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2014.3408</pub-id><pub-id pub-id-type="pmid">26090712</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Dai</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Shi</surname> <given-names>R</given-names></name> <name><surname>Hui</surname> <given-names>Y</given-names></name> <name><surname>Jin</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment</article-title>. <source>Nat Commun.</source> (<year>2020</year>) <volume>11</volume>:<fpage>855</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-14676-4</pub-id><pub-id pub-id-type="pmid">32071312</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yildirim</surname> <given-names>A</given-names></name> <name><surname>Arabaci Tamer</surname> <given-names>S</given-names></name> <name><surname>Sahin</surname> <given-names>D</given-names></name> <name><surname>Bagriacik</surname> <given-names>F</given-names></name> <name><surname>Kahraman</surname> <given-names>MM</given-names></name> <name><surname>Onur</surname> <given-names>ND</given-names></name> <etal/></person-group>. <article-title>The effects of antibiotics and melatonin on hepato-intestinal inflammation and gut microbial dysbiosis induced by a short-term high-fat diet consumption in rats</article-title>. <source>Br J Nutr.</source> (<year>2019</year>) <volume>122</volume>:<fpage>841</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114519001466</pub-id><pub-id pub-id-type="pmid">31217044</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fadrosh</surname> <given-names>DW</given-names></name> <name><surname>Ma</surname> <given-names>B</given-names></name> <name><surname>Gajer</surname> <given-names>P</given-names></name> <name><surname>Sengamalay</surname> <given-names>N</given-names></name> <name><surname>Ott</surname> <given-names>S</given-names></name> <name><surname>Brotman</surname> <given-names>RM</given-names></name> <etal/></person-group>. <article-title>An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform</article-title>. <source>Microbiome.</source> (<year>2014</year>) <volume>2</volume>:<fpage>6</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1186/2049-2618-2-6</pub-id><pub-id pub-id-type="pmid">24558975</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>RC</given-names></name></person-group>. <article-title>UPARSE. highly accurate OTU sequences from microbial amplicon reads</article-title>. <source>Nat Methods.</source> (<year>2013</year>) <volume>10</volume>:<fpage>996</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2604</pub-id><pub-id pub-id-type="pmid">23955772</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langille</surname> <given-names>MG</given-names></name> <name><surname>Zaneveld</surname> <given-names>J</given-names></name> <name><surname>Caporaso</surname> <given-names>JG</given-names></name> <name><surname>McDonald</surname> <given-names>D</given-names></name> <name><surname>Knights</surname> <given-names>D</given-names></name> <name><surname>Reyes</surname> <given-names>JA</given-names></name> <etal/></person-group>. <article-title>Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences</article-title>. <source>Nat Biotechnol.</source> (<year>2013</year>) <volume>31</volume>:<fpage>814</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2676</pub-id><pub-id pub-id-type="pmid">23975157</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>K</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <name><surname>Dou</surname> <given-names>XX</given-names></name> <name><surname>Wang</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>JX</given-names></name> <name><surname>Zhang</surname> <given-names>WM</given-names></name> <etal/></person-group>. <article-title>Doses Lactobacillus reuteri depend on adhesive ability to modulate the intestinal immune response and metabolism in mice challenged with lipopolysaccharide</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>28332</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/srep28332</pub-id><pub-id pub-id-type="pmid">27323686</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kind</surname> <given-names>T</given-names></name> <name><surname>Wohlgemuth</surname> <given-names>G</given-names></name> <name><surname>Lee</surname> <given-names>DY</given-names></name> <name><surname>Lu</surname> <given-names>Y</given-names></name> <name><surname>Palazoglu</surname> <given-names>M</given-names></name> <name><surname>Shahbaz</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry</article-title>. <source>Anal Chem.</source> (<year>2009</year>) <volume>81</volume>:<fpage>10038</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1021/ac9019522</pub-id><pub-id pub-id-type="pmid">19928838</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname> <given-names>WB</given-names></name> <name><surname>Broadhurst</surname> <given-names>D</given-names></name> <name><surname>Begley</surname> <given-names>P</given-names></name> <name><surname>Zelena</surname> <given-names>E</given-names></name> <name><surname>Francis-McIntyre</surname> <given-names>S</given-names></name> <name><surname>Anderson</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry</article-title>. <source>Nat Protoc.</source> (<year>2011</year>) <volume>6</volume>:<fpage>1060</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2011.335</pub-id><pub-id pub-id-type="pmid">21720319</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname> <given-names>J</given-names></name> <name><surname>Soufan</surname> <given-names>O</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Caraus</surname> <given-names>I</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Bourque</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis</article-title>. <source>Nucleic Acids Res.</source> (<year>2018</year>) <volume>46</volume>:<fpage>W486</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky310</pub-id><pub-id pub-id-type="pmid">29762782</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klempel</surname> <given-names>MC</given-names></name> <name><surname>Kroeger</surname> <given-names>CM</given-names></name> <name><surname>Varady</surname> <given-names>KA</given-names></name></person-group>. <article-title>Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet</article-title>. <source>Metabolism.</source> (<year>2013</year>) <volume>62</volume>:<fpage>137</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2012.07.002</pub-id><pub-id pub-id-type="pmid">22889512</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anton</surname> <given-names>SD</given-names></name> <name><surname>Moehl</surname> <given-names>K</given-names></name> <name><surname>Donahoo</surname> <given-names>WT</given-names></name> <name><surname>Marosi</surname> <given-names>K</given-names></name> <name><surname>Lee</surname> <given-names>SA</given-names></name> <name><surname>Mainous</surname> <given-names>AG</given-names> <suffix>3rd</suffix></name> <etal/></person-group>. <article-title>Flipping the metabolic switch: understanding and applying the health benefits of fasting</article-title>. <source>Obesity.</source> (<year>2018</year>) <volume>26</volume>:<fpage>254</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/oby.22065</pub-id><pub-id pub-id-type="pmid">29086496</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>TL</given-names></name> <name><surname>Kiersgaard</surname> <given-names>MK</given-names></name> <name><surname>Sorensen</surname> <given-names>DB</given-names></name> <name><surname>Mikkelsen</surname> <given-names>LF</given-names></name></person-group>. <article-title>Fasting of mice: a review</article-title>. <source>Lab Anim.</source> (<year>2013</year>) <volume>47</volume>:<fpage>225</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1177/0023677213501659</pub-id><pub-id pub-id-type="pmid">24025567</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurokawa</surname> <given-names>M</given-names></name> <name><surname>Akino</surname> <given-names>K</given-names></name> <name><surname>Kanda</surname> <given-names>KA</given-names></name></person-group>. <article-title>New apparatus for studying feeding and drinking in the mouse</article-title>. <source>Physiol Behav.</source> (<year>2000</year>) <volume>70</volume>:<fpage>105</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(00)00226-2</pub-id><pub-id pub-id-type="pmid">10978484</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G</given-names></name> <name><surname>Xie</surname> <given-names>C</given-names></name> <name><surname>Lu</surname> <given-names>S</given-names></name> <name><surname>Nichols</surname> <given-names>RG</given-names></name> <name><surname>Tian</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota</article-title>. <source>Cell metabolism</source>. (<year>2017</year>) <volume>26</volume>:<fpage>672</fpage>&#x02013;<lpage>85.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.08.019</pub-id><pub-id pub-id-type="pmid">29117546</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cipolla-Neto</surname> <given-names>J</given-names></name> <name><surname>Amaral</surname> <given-names>FG</given-names></name> <name><surname>Afeche</surname> <given-names>SC</given-names></name> <name><surname>Tan</surname> <given-names>DX</given-names></name> <name><surname>Reiter</surname> <given-names>RJ</given-names></name></person-group>. <article-title>Melatonin, energy metabolism, and obesity: a review</article-title>. <source>J Pineal Res.</source> (<year>2014</year>) <volume>56</volume>:<fpage>371</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1111/jpi.12137</pub-id><pub-id pub-id-type="pmid">24654916</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>R&#x000ED;os-Lugo</surname> <given-names>MJ</given-names></name> <name><surname>Cano</surname> <given-names>P</given-names></name> <name><surname>Jim&#x000E9;nez-Ortega</surname> <given-names>V</given-names></name> <name><surname>Fern&#x000E1;ndez-Mateos</surname> <given-names>MP</given-names></name> <name><surname>Scacchi</surname> <given-names>PA</given-names></name> <name><surname>Cardinali</surname> <given-names>DP</given-names></name> <etal/></person-group>. <article-title>Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats</article-title>. <source>J Pineal Res.</source> (<year>2010</year>) <volume>49</volume>:<fpage>342</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-079X.2010.00798.x</pub-id><pub-id pub-id-type="pmid">20663045</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prunet-Marcassus</surname> <given-names>B</given-names></name> <name><surname>Desbazeille</surname> <given-names>M</given-names></name> <name><surname>Bros</surname> <given-names>A</given-names></name> <name><surname>Louche</surname> <given-names>K</given-names></name> <name><surname>Delagrange</surname> <given-names>P</given-names></name> <name><surname>Renard</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity</article-title>. <source>Endocrinology.</source> (<year>2003</year>) <volume>144</volume>:<fpage>5347</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1210/en.2003-0693</pub-id><pub-id pub-id-type="pmid">12970162</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>SF</given-names></name> <name><surname>Nyachoti</surname> <given-names>M</given-names></name></person-group>. <article-title>Using probiotics to improve swine gut health and nutrient utilization</article-title>. <source>Anim Nutr.</source> (<year>2017</year>) <volume>3</volume>:<fpage>331</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.aninu.2017.06.007</pub-id><pub-id pub-id-type="pmid">29767089</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pluske</surname> <given-names>JR</given-names></name> <name><surname>Williams</surname> <given-names>IH</given-names></name> <name><surname>Aherne</surname> <given-names>FX</given-names></name></person-group>. <article-title>Villous height and crypt depth in piglets in response to increases in the intake of cows&#x00027; milk after weaning</article-title>. <source>Anim Sci.</source> (<year>1996</year>) <volume>62</volume>:<fpage>145</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1017/S1357729800014429</pub-id><pub-id pub-id-type="pmid">30886898</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname> <given-names>P</given-names></name> <name><surname>Kumar</surname> <given-names>M</given-names></name> <name><surname>Sharma</surname> <given-names>G</given-names></name> <name><surname>Barak</surname> <given-names>P</given-names></name> <name><surname>Das</surname> <given-names>S</given-names></name> <name><surname>Kamat</surname> <given-names>SS</given-names></name> <etal/></person-group>. <article-title>Kinesin-dependent mechanism for controlling triglyceride secretion from the liver</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2017</year>) <volume>114</volume>:<fpage>12958</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1713292114</pub-id><pub-id pub-id-type="pmid">29158401</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>M</given-names></name> <name><surname>Ojha</surname> <given-names>S</given-names></name> <name><surname>Rai</surname> <given-names>P</given-names></name> <name><surname>Joshi</surname> <given-names>A</given-names></name> <name><surname>Kamat</surname> <given-names>SS</given-names></name> <name><surname>Mallik</surname> <given-names>R</given-names></name></person-group>. <article-title>Insulin activates intracellular transport of lipid droplets to release triglycerides from the liver</article-title>. <source>J Cell Biol.</source> (<year>2019</year>) <volume>218</volume>:<fpage>3697</fpage>&#x02013;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201903102</pub-id><pub-id pub-id-type="pmid">31604801</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name> <name><surname>Ley</surname> <given-names>RE</given-names></name> <name><surname>Mahowald</surname> <given-names>MA</given-names></name> <name><surname>Magrini</surname> <given-names>V</given-names></name> <name><surname>Mardis</surname> <given-names>ER</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>. <source>Nature.</source> (<year>2006</year>) <volume>444</volume>:<fpage>1027</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nature05414</pub-id><pub-id pub-id-type="pmid">17183312</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name> <name><surname>B&#x000E4;ckhed</surname> <given-names>F</given-names></name> <name><surname>Fulton</surname> <given-names>L</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome</article-title>. <source>Cell Host Microbe.</source> (<year>2008</year>) <volume>3</volume>:<fpage>213</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2008.02.015</pub-id><pub-id pub-id-type="pmid">18407065</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname> <given-names>C</given-names></name> <name><surname>Stojanovic</surname> <given-names>O</given-names></name> <name><surname>Colin</surname> <given-names>DJ</given-names></name> <name><surname>Suarez-Zamorano</surname> <given-names>N</given-names></name> <name><surname>Tarallo</surname> <given-names>V</given-names></name> <name><surname>Veyrat-Durebex</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Gut microbiota orchestrates energy homeostasis during cold</article-title>. <source>Cell.</source> (<year>2015</year>) <volume>163</volume>:<fpage>1360</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.11.004</pub-id><pub-id pub-id-type="pmid">26638070</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Zhu</surname> <given-names>C</given-names></name> <name><surname>Mou</surname> <given-names>H</given-names></name> <name><surname>Kong</surname> <given-names>Q</given-names></name></person-group>. <article-title>Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria</article-title>. <source>Crit Rev Food Sci Nutr.</source> (<year>2019</year>) <volume>59</volume>:<fpage>S130</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2018.1542587</pub-id><pub-id pub-id-type="pmid">30580556</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clausen</surname> <given-names>MR</given-names></name> <name><surname>Mortensen</surname> <given-names>PB</given-names></name></person-group>. <article-title>Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis</article-title>. <source>Gut.</source> (<year>1995</year>) <volume>37</volume>:<fpage>684</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/gut.37.5.684</pub-id><pub-id pub-id-type="pmid">8549946</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drissi</surname> <given-names>F</given-names></name> <name><surname>Raoult</surname> <given-names>D</given-names></name> <name><surname>Merhej</surname> <given-names>V</given-names></name></person-group>. <article-title>Metabolic role of lactobacilli in weight modification in humans and animals</article-title>. <source>Microb Pathog.</source> (<year>2017</year>) <volume>106</volume>:<fpage>182</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2016.03.006</pub-id><pub-id pub-id-type="pmid">27033001</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umbrello</surname> <given-names>G</given-names></name> <name><surname>Esposito</surname> <given-names>S</given-names></name></person-group>. <article-title>Microbiota and neurologic diseases: potential effects of probiotics</article-title>. <source>J Transl Med.</source> (<year>2016</year>) <volume>14</volume>:<fpage>298</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-016-1058-7</pub-id><pub-id pub-id-type="pmid">27756430</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Everard</surname> <given-names>A</given-names></name> <name><surname>Belzer</surname> <given-names>C</given-names></name> <name><surname>Geurts</surname> <given-names>L</given-names></name> <name><surname>Ouwerkerk</surname> <given-names>JP</given-names></name> <name><surname>Druart</surname> <given-names>C</given-names></name> <name><surname>Bindels</surname> <given-names>LB</given-names></name> <etal/></person-group>. <article-title>Cross-talk between <italic>Akkermansia muciniphila</italic> and intestinal epithelium controls diet-induced obesity</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2013</year>) <volume>110</volume>:<fpage>9066</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1219451110</pub-id><pub-id pub-id-type="pmid">23671105</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reunanen</surname> <given-names>J</given-names></name> <name><surname>Kainulainen</surname> <given-names>V</given-names></name> <name><surname>Huuskonen</surname> <given-names>L</given-names></name> <name><surname>Ottman</surname> <given-names>N</given-names></name> <name><surname>Belzer</surname> <given-names>C</given-names></name> <name><surname>Huhtinen</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title><italic>Akkermansia muciniphila</italic> adheres to enterocytes and strengthens the integrity of the epithelial cell layer</article-title>. <source>Appl Environ Microbiol.</source> (<year>2015</year>) <volume>81</volume>:<fpage>3655</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.04050-14</pub-id><pub-id pub-id-type="pmid">25795669</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sonoyama</surname> <given-names>K</given-names></name> <name><surname>Fujiwara</surname> <given-names>R</given-names></name> <name><surname>Takemura</surname> <given-names>N</given-names></name> <name><surname>Ogasawara</surname> <given-names>T</given-names></name> <name><surname>Watanabe</surname> <given-names>J</given-names></name> <name><surname>Ito</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Response of gut microbiota to fasting and hibernation in Syrian hamsters</article-title>. <source>Appl Environ Microbiol.</source> (<year>2009</year>) <volume>75</volume>:<fpage>6451</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00692-09</pub-id><pub-id pub-id-type="pmid">19700553</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cignarella</surname> <given-names>F</given-names></name> <name><surname>Cantoni</surname> <given-names>C</given-names></name> <name><surname>Ghezzi</surname> <given-names>L</given-names></name> <name><surname>Salter</surname> <given-names>A</given-names></name> <name><surname>Dorsett</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota</article-title>. <source>Cell Metabol</source>. (<year>2018</year>) <volume>27</volume>:<fpage>1222</fpage>&#x02013;<lpage>35.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2018.05.006</pub-id><pub-id pub-id-type="pmid">29874567</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Puchalska</surname> <given-names>P</given-names></name> <name><surname>Crawford</surname> <given-names>PA</given-names></name></person-group>. <article-title>Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics</article-title>. <source>Cell Metab.</source> (<year>2017</year>) <volume>25</volume>:<fpage>262</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.12.022</pub-id><pub-id pub-id-type="pmid">28178565</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>ALT</term>
<def><p>alanine aminotransferase</p></def></def-item>
<def-item><term>AST</term>
<def><p>aspartate aminotransferase</p></def></def-item>
<def-item><term>eWAT</term>
<def><p>epididymal white adipose tissue</p></def></def-item>
<def-item><term>FC</term>
<def><p>fold change</p></def></def-item>
<def-item><term>FDR</term>
<def><p>false discovery rate</p></def></def-item>
<def-item><term>Glu</term>
<def><p>glucose</p></def></def-item>
<def-item><term>HDL-C</term>
<def><p>high density lipoproteins cholesterol</p></def></def-item>
<def-item><term>IF</term>
<def><p>Intermittent fasting</p></def></def-item>
<def-item><term>KEGG</term>
<def><p>Kyoto Encyclopedia of Genes and Genomes</p></def></def-item>
<def-item><term>LDA</term>
<def><p>linear discriminant analysis</p></def></def-item>
<def-item><term>LDL-C</term>
<def><p>low density lipoproteins cholesterol</p></def></def-item>
<def-item><term>OTU</term>
<def><p>operational taxonomic units</p></def></def-item>
<def-item><term>PCoA</term>
<def><p>principal component analysis</p></def></def-item>
<def-item><term>PLS-DA</term>
<def><p>partial least squares-discriminant analysis</p></def></def-item>
<def-item><term>RT</term>
<def><p>retention time</p></def></def-item>
<def-item><term>TC</term>
<def><p>total cholesterol</p></def></def-item>
<def-item><term>TEM</term>
<def><p>Transmission electron microscopy</p></def></def-item>
<def-item><term>TG</term>
<def><p>triglyceride</p></def></def-item>
<def-item><term>VIP</term>
<def><p>variable importance in projection.</p></def></def-item>
</def-list>
</glossary> 
</back>
</article>